Skip to main content
. 2016 Jul 22;7(35):56781–56797. doi: 10.18632/oncotarget.10788

Table 1. Clinical and histopathological information for HPV(+) and HPV(−) HNSCC patients.

Variable Description HPV(+) HPV(−) p-value Test
(n=10) (n=13)
Gender % Male 90.00 76.92 6.04E-01 a
Age Mean 56.90 ± 8.66 63.77 ± 15.85 2.32E-01 b
Collection site Liverpool 1 0
Poole 2 6 2.81E-01 a
Southampton 7 7
Sequencing Batch 1 3 6
2 7 5 3.92E-01 a
3 0 2
RIN* Mean 8.51 ± 0.80 8.51 ± 1.01 7.56E-01 c
Smoking Non smoker 10 6
Smoker 0 4 2.56E-02 a
Heavy smoker 0 3
Alcohol Non drinker 5 3
Moderate drinker 4 9 4.02E-01 a
Heavy drinker 1 1
Tumor site Larynx 0 4
Oral 0 5 1.60E-03 a
Oropharynx 10 4
White blood cells Mean 9.47 ± 2.23 8.52 ± 1.92 2.86E-01 b
Lymphocytes Mean 1.82 ± 0.60 1.77 ± 0.81 5.76E-01 c
Staging I 0 3
II 1 0 3.48E-01 a
III 2 3
IV 7 7
TIL status High 8 4 3.61E-02 a
Medium 2 9
Pattern of invasion Cohesive 10 6 7.49E-03 a
Discohesive 0 7
Differentiation Poor 9 2
Moderate 1 9 8.85E-04 a
Well 0 2
Smooth muscle actin Low 10 9
Moderate 0 2 2.37E-01 a
High 0 2
Tumor cell % 68.00 ± 20.58 65.38 ± 21.06 7.69E-01 B
E6 expression Mean 4.57 ± 1.11 −4.36 ± 0.57 1.75E-06 C
E7 expression Mean 5.07 ± 1.30 −4.36 ± 0.57 1.75E-06 C
*

RIN; RNA integrity number

P-values were obtained from Fisher's exact test (a) for categorical variables. A two sample t-test (b) was performed for numerical variables with normal distribution (Shapiro-Wilk test, P≥0.05). A Wilcoxon rank sum test (c) was performed for numerical variables with non-normal distribution (Shapiro-Wilk test, P<0.05). Statistically significant p-values (<0.05) are indicated in bold.